McKesson Corporation (MCK)
| Bid | 709 |
| Market Cap | 89.33B |
| Revenue (ttm) | 344.58B |
| Net Income (ttm) | 2.83B |
| EPS (ttm) | 21.78 |
| PE Ratio (ttm) | 32.73 |
| Forward PE | 19.34 |
| Analyst | Buy |
| Ask | 713 |
| Volume | 670,938 |
| Avg. Volume (20D) | 1,002,336 |
| Open | 710.87 |
| Previous Close | 707.28 |
| Day's Range | 705.40 - 715.11 |
| 52-Week Range | 464.42 - 728.32 |
| Beta | 0.49 |
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management,...
Analyst Forecast
According to 14 analyst ratings, the average rating for MCK stock is "Buy." The 12-month stock price forecast is $675, which is a decrease of -5.30% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago · benzinga.com
McKesson Shares Rise Nearly 1% After Key SignalMCK moves higher through the session after Alert
2 weeks ago · businesswire.com
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community OncologyIRVING, Texas--(BUSINESS WIRE)--McKesson launched an initiative addressing the clinical challenges and administrative burden practices face in the era of biomarker-directed care.
